Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection

Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of...

Full description

Saved in:
Bibliographic Details
Published inSurgery Vol. 159; no. 4; pp. 1090 - 1098
Main Authors Lee, Ju-Hee, Kim, Hyun-Il, Kim, Min Gyu, Ha, Tae Kyung, Jung, Min-Sung, Kwon, Sung Joon
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2016
Subjects
Online AccessGet full text
ISSN0039-6060
1532-7361
1532-7361
DOI10.1016/j.surg.2015.11.002

Cover

Abstract Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.
AbstractList Background Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Methods Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Results Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% ( n  = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence ( n  = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. Conclusion pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.
Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.
Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients.BACKGROUNDLate recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients.Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed.METHODSClinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed.Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence.RESULTSAmong 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8-238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence.pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.CONCLUSIONpT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.
Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this study was to evaluate the predictors and status of tumor recurrence among these patients. Clinicopathologic characteristics, patterns of recurrence, and postrecurrence survival were analyzed in patients who were diagnosed as disease free at 5 years postoperatively and thereafter experienced recurrence. Independent factors associated with the late recurrence were analyzed. Among 1,573 patients who underwent curative surgery from June 1992 to December 2006, 348 patients had recurrence. Of them, 7.6% (n = 25) suffered from late recurrence after 5 years after gastrectomy. Among patients who were diagnosed as disease free at 5 years after surgery, it accounted for 2.8% (25/902). Cases with late recurrence were characterized by more aggressive clinicopathologic features than those without recurrence. The median time to recurrence was 88.8 months (range, 64.8–238.0); of the 25 patients, 18 (72.0%) had recurrence within 8 years after surgery. The most common pattern was peritoneal recurrence (n = 19; 76.0%). The estimated median survival after recurrence was 9.4 months. On multivariate analysis, pT4 classification was the only independent risk factor for late recurrence. There were 185 patients with pT4 tumor who had no recurrence at 5 years after surgery; 19 (10.3%) had late recurrence. pT4 tumor was the only important predictor of late recurrence. Whether extended follow-up for T4 tumors affects survival needs to be demonstrated in more large-scale studies.
Author Lee, Ju-Hee
Kwon, Sung Joon
Jung, Min-Sung
Kim, Min Gyu
Ha, Tae Kyung
Kim, Hyun-Il
Author_xml – sequence: 1
  givenname: Ju-Hee
  surname: Lee
  fullname: Lee, Ju-Hee
  organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea
– sequence: 2
  givenname: Hyun-Il
  surname: Kim
  fullname: Kim, Hyun-Il
  organization: Department of Surgery, Hanyang University Guri Hospital, Guri, Republic of Korea
– sequence: 3
  givenname: Min Gyu
  surname: Kim
  fullname: Kim, Min Gyu
  organization: Department of Surgery, Hanyang University Guri Hospital, Guri, Republic of Korea
– sequence: 4
  givenname: Tae Kyung
  surname: Ha
  fullname: Ha, Tae Kyung
  organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea
– sequence: 5
  givenname: Min-Sung
  surname: Jung
  fullname: Jung, Min-Sung
  organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea
– sequence: 6
  givenname: Sung Joon
  surname: Kwon
  fullname: Kwon, Sung Joon
  email: sjkwon@hanyang.ac.kr
  organization: Department of Surgery, Hanyang University Hospital, Seoul, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26747230$$D View this record in MEDLINE/PubMed
BookMark eNqFks2KFDEUhYOMOD2jL-BCsnRTZW6SSlWJCMPgHwwI_oC7kE7dzKStrrRJSum38Vl8MlN062LAcRW4nO_ccM49IydTmJCQx8BqYKCebeo0x-uaM2hqgJoxfo-soBG8aoWCE7JiTPSVYoqdkrOUNoyxXkL3gJxy1cqWC7Yi4we0c4w4WaTB0WuTcvSWWlMGkfqJ7kz2OOVEf9wEaiLSwSc0CSsXEakLkW5DmeYbM9Hm1889mpiocbnQu-i3Ju5pxIQ2-zA9JPedGRM-Or7n5PPrV58u31ZX79-8u7y4qmzDu1w56AapOMNGtd3AHeccXY8dSNdIodYcG47QMmihl70Ua1BcKbnmXbfu-NCLc_L04LuL4duMKeutTxbH0UwY5qShbXknpJSiSJ8cpfN6i4M-_ln_SagI-EFgY0gpovsrAaaXGvRGLzXopQYNoEsNBepuQdZns0SQo_Hj3eiLA4oloO8eo07WL_UMPpYU9RD83fjLW7gd_eStGb_iHtMmzHEq0WvQiWumPy4nslwINOU4RPulGDz_t8H_tv8Gt0nLbw
CitedBy_id crossref_primary_10_4166_kjg_2019_73_3_141
crossref_primary_10_1007_s11605_023_05823_5
crossref_primary_10_1007_s10120_020_01147_4
crossref_primary_10_1007_s10120_022_01331_8
crossref_primary_10_1002_cam4_3899
crossref_primary_10_1016_j_gassur_2025_101958
crossref_primary_10_3892_ol_2019_10677
crossref_primary_10_1097_JS9_0000000000000731
crossref_primary_10_1007_s00464_021_08337_w
crossref_primary_10_47429_lmo_2021_11_4_305
crossref_primary_10_1620_tjem_250_31
crossref_primary_10_1186_s40792_023_01660_5
crossref_primary_10_1007_s13691_021_00518_7
crossref_primary_10_1016_j_ejso_2022_01_018
crossref_primary_10_3389_fonc_2024_1326970
crossref_primary_10_1007_s12328_020_01143_2
crossref_primary_10_4143_crt_2019_210
crossref_primary_10_3389_fmolb_2021_744677
crossref_primary_10_1007_s12328_020_01315_0
crossref_primary_10_1007_s10120_024_01558_7
crossref_primary_10_1016_j_ejso_2022_04_018
crossref_primary_10_2169_internalmedicine_3847_19
crossref_primary_10_2147_CMAR_S264582
crossref_primary_10_1097_MD_0000000000029533
crossref_primary_10_1155_2022_4510000
crossref_primary_10_1001_jamasurg_2024_1754
crossref_primary_10_1001_jamasurg_2024_1753
crossref_primary_10_1007_s12029_021_00684_0
crossref_primary_10_1001_jamasurg_2024_4282
crossref_primary_10_1155_2016_2408645
crossref_primary_10_1186_s40792_019_0664_z
crossref_primary_10_3389_fonc_2023_1158863
crossref_primary_10_1007_s00423_020_01996_8
crossref_primary_10_3389_fonc_2020_01469
crossref_primary_10_3389_fonc_2023_1283274
Cites_doi 10.1093/annonc/mdp122
10.4251/wjgo.v4.i2.16
10.1038/nrc2256
10.1159/000227367
10.1200/JCO.2013.48.8585
10.1002/ssu.1046
10.1007/s101200050006
10.3322/caac.20107
10.1200/jco.2002.08.003
10.1007/BF01270600
10.1016/S0140-6736(10)61121-X
10.1016/S0140-6736(13)61719-5
10.1007/s10120-011-0042-4
10.1159/000320691
10.1046/j.1365-2036.16.s2.33.x
10.1038/bjc.2012.326
10.1016/j.cell.2013.10.029
10.1158/1078-0432.CCR-07-4354
10.1245/s10434-007-9479-4
10.1046/j.1365-2168.2000.01360.x
10.1016/j.ccr.2013.04.017
10.1038/sj.bjc.6605085
ContentType Journal Article
Copyright 2016 Elsevier Inc.
Elsevier Inc.
Copyright © 2016 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2016 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2016 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.surg.2015.11.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1532-7361
EndPage 1098
ExternalDocumentID 26747230
10_1016_j_surg_2015_11_002
S003960601500937X
1_s2_0_S003960601500937X
Genre Evaluation Studies
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
123
1B1
1CY
1P~
1~.
1~5
354
4.4
457
4CK
4G.
53G
5RE
5VS
7-5
71M
8F7
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABCQX
ABFNM
ABFRF
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACIEU
ACRLP
ACRPL
ACVFH
ACWUS
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FD6
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M41
MO0
N4W
N9A
O-L
O9-
OAUVE
OBH
OHH
OJ0
OV0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSZ
T5K
TEORI
UDS
UGJ
UHS
UQV
UQZ
UV1
VVN
WH7
X7M
YOC
Z5R
ZGI
ZXP
ZY1
~G-
AACTN
AFKWA
AJOXV
AMFUW
PKN
RIG
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
ZA5
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c528t-f18d4620e5678d2f222ef9e814f5436b2e52e17017194943b162664b288b82d93
IEDL.DBID AIKHN
ISSN 0039-6060
1532-7361
IngestDate Thu Sep 04 21:37:15 EDT 2025
Mon Jul 21 05:57:38 EDT 2025
Thu Apr 24 23:01:59 EDT 2025
Tue Jul 01 02:47:56 EDT 2025
Fri Feb 23 02:24:43 EST 2024
Tue Feb 25 20:06:36 EST 2025
Tue Aug 26 16:40:42 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2016 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c528t-f18d4620e5678d2f222ef9e814f5436b2e52e17017194943b162664b288b82d93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
PMID 26747230
PQID 1772834443
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1772834443
pubmed_primary_26747230
crossref_primary_10_1016_j_surg_2015_11_002
crossref_citationtrail_10_1016_j_surg_2015_11_002
elsevier_sciencedirect_doi_10_1016_j_surg_2015_11_002
elsevier_clinicalkeyesjournals_1_s2_0_S003960601500937X
elsevier_clinicalkey_doi_10_1016_j_surg_2015_11_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Surgery
PublicationTitleAlternate Surgery
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Eom, Yoon, Ryu, Lee, Cho, Lee (bib8) 2010; 27
Koga, Kaibara, Kishimoto, Nishidoi, Kimura, Okamoto (bib5) 1982; 356
Kienle, Koch (bib19) 2001; 20
Kim, Chang, Roh, Chae, Yang, Choi (bib2) 2003; 65
Kim, Lee, Kim, Yu, Yang (bib10) 1998; 1
Iwatsuki, Fukagawa, Mimori, Nakanishi, Ito, Ishii (bib25) 2009; 100
(bib7) 2011; 14
Fuchs, Tomasek, Yong, Dumitru, Passalacqua, Goswami (bib13) 2014; 383
Bang, Van Cutsem, Feyereislova, Chung, Shen, Sawaki (bib14) 2010; 376
Jackson, Cunningham, Oliveira (bib11) 2009; 20
Giancotti (bib18) 2013; 155
Yoo, Noh, Shin, Choi, Min (bib9) 2000; 87
Li, Qin, Xu, Guo, Xiong, Bai (bib15) 2013; 31
Baiocchi, D'Ugo, Coit, Hardwick, Kassab, Nashimoto (bib12) 2015
Jemal, Bray, Center, Ferlay, Ward, Forman (bib1) 2011; 61
Griniatsos, Michail, Dimitriou, Karavokyros (bib22) 2012; 4
Kang, Pantel (bib17) 2013; 23
Akiyoshi, Fukagawa, Ueo, Ishibashi, Takahashi, Fabbri (bib24) 2012; 107
Heiss, Simon, Beyer, Gruetzner, Tarabichi, Babic (bib23) 2002; 20
Maehara, Okuyama, Oshiro, Baba, Adachi, Sugimachi (bib6) 1994; 51
Park, Kwon, Lee (bib4) 2000; 59
Mimori, Fukagawa, Kosaka, Kita, Ishikawa, Etoh (bib21) 2008; 14
Moon, Jeung, Rha, Yoo, Roh, Noh (bib3) 2007; 14
Shin, Chung, Kim, Kim, Hur, Rhim (bib20) 2002; 16
Aguirre-Ghiso (bib16) 2007; 7
Jemal (10.1016/j.surg.2015.11.002_bib1) 2011; 61
Kienle (10.1016/j.surg.2015.11.002_bib19) 2001; 20
Iwatsuki (10.1016/j.surg.2015.11.002_bib25) 2009; 100
Kim (10.1016/j.surg.2015.11.002_bib2) 2003; 65
Griniatsos (10.1016/j.surg.2015.11.002_bib22) 2012; 4
Park (10.1016/j.surg.2015.11.002_bib4) 2000; 59
Li (10.1016/j.surg.2015.11.002_bib15) 2013; 31
Eom (10.1016/j.surg.2015.11.002_bib8) 2010; 27
Jackson (10.1016/j.surg.2015.11.002_bib11) 2009; 20
Heiss (10.1016/j.surg.2015.11.002_bib23) 2002; 20
Shin (10.1016/j.surg.2015.11.002_bib20) 2002; 16
Moon (10.1016/j.surg.2015.11.002_bib3) 2007; 14
Koga (10.1016/j.surg.2015.11.002_bib5) 1982; 356
Kim (10.1016/j.surg.2015.11.002_bib10) 1998; 1
Bang (10.1016/j.surg.2015.11.002_bib14) 2010; 376
Kang (10.1016/j.surg.2015.11.002_bib17) 2013; 23
Baiocchi (10.1016/j.surg.2015.11.002_bib12) 2015
Mimori (10.1016/j.surg.2015.11.002_bib21) 2008; 14
Maehara (10.1016/j.surg.2015.11.002_bib6) 1994; 51
Akiyoshi (10.1016/j.surg.2015.11.002_bib24) 2012; 107
Aguirre-Ghiso (10.1016/j.surg.2015.11.002_bib16) 2007; 7
Yoo (10.1016/j.surg.2015.11.002_bib9) 2000; 87
(10.1016/j.surg.2015.11.002_bib7) 2011; 14
Giancotti (10.1016/j.surg.2015.11.002_bib18) 2013; 155
Fuchs (10.1016/j.surg.2015.11.002_bib13) 2014; 383
References_xml – volume: 87
  start-page: 236
  year: 2000
  end-page: 242
  ident: bib9
  article-title: Recurrence following curative resection for gastric carcinoma
  publication-title: Br J Surg
– volume: 356
  start-page: 37
  year: 1982
  end-page: 42
  ident: bib5
  article-title: Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability
  publication-title: Langenbecks Arch Chir
– volume: 20
  start-page: 34
  year: 2009
  end-page: 36
  ident: bib11
  article-title: Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
– volume: 14
  start-page: 113
  year: 2011
  end-page: 123
  ident: bib7
  article-title: Japanese gastric cancer treatment guidelines 2010 (ver. 3)
  publication-title: Gastric Cancer
– volume: 31
  start-page: 3219
  year: 2013
  end-page: 3225
  ident: bib15
  article-title: Apatinib for chemotherapy refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel arm, phase II trial
  publication-title: J Clin Oncol
– volume: 376
  start-page: 687
  year: 2010
  end-page: 697
  ident: bib14
  article-title: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
  publication-title: Lancet
– volume: 14
  start-page: 2609
  year: 2008
  end-page: 2616
  ident: bib21
  article-title: Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1
  publication-title: Clin Cancer Res
– volume: 4
  start-page: 16
  year: 2012
  end-page: 21
  ident: bib22
  article-title: Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance
  publication-title: World J Gastrointest Oncol
– volume: 16
  start-page: 137
  year: 2002
  end-page: 144
  ident: bib20
  article-title: Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs
  publication-title: Aliment Pharmacol Ther
– volume: 51
  start-page: 366
  year: 1994
  end-page: 371
  ident: bib6
  article-title: Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer
  publication-title: Oncology
– volume: 100
  start-page: 1937
  year: 2009
  end-page: 1942
  ident: bib25
  article-title: Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis
  publication-title: Br J Cancer
– year: 2015
  ident: bib12
  article-title: Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
  publication-title: Gastric Cancer
– volume: 20
  start-page: 2005
  year: 2002
  end-page: 2016
  ident: bib23
  article-title: Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow
  publication-title: J Clin Oncol
– volume: 27
  start-page: 481
  year: 2010
  end-page: 486
  ident: bib8
  article-title: Predictors of timing and patterns of recurrence after curative resection for gastric cancer
  publication-title: Dig Surg
– volume: 14
  start-page: 2730
  year: 2007
  end-page: 2737
  ident: bib3
  article-title: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute
  publication-title: Ann Surg Oncol
– volume: 7
  start-page: 834
  year: 2007
  end-page: 846
  ident: bib16
  article-title: Models, mechanisms and clinical evidence for cancer dormancy
  publication-title: Nat Rev Cancer
– volume: 155
  start-page: 750
  year: 2013
  end-page: 764
  ident: bib18
  article-title: Mechanisms governing metastatic dormancy and reactivation
  publication-title: Cell
– volume: 107
  start-page: 1345
  year: 2012
  end-page: 1353
  ident: bib24
  article-title: Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
  publication-title: Br J Cancer
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  ident: bib1
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
– volume: 1
  start-page: 125
  year: 1998
  end-page: 133
  ident: bib10
  article-title: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer
  publication-title: Gastric Cancer
– volume: 23
  start-page: 573
  year: 2013
  end-page: 581
  ident: bib17
  article-title: Tumor cell dissemination: emerging biological insights from animal models and cancer patients
  publication-title: Cancer Cell
– volume: 65
  start-page: 301
  year: 2003
  end-page: 308
  ident: bib2
  article-title: Factors influencing recurrence after curative resection for advanced gastric cancer
  publication-title: J Korean Surg Soc
– volume: 20
  start-page: 282
  year: 2001
  end-page: 293
  ident: bib19
  article-title: Minimal residual disease in gastrointestinal cancer
  publication-title: Semin Surg Oncol
– volume: 59
  start-page: 778
  year: 2000
  end-page: 785
  ident: bib4
  article-title: Clinicopathological characteristics of recurred gastric cancer patients after curative surgery
  publication-title: J Korean Surg Soc
– volume: 383
  start-page: 31
  year: 2014
  end-page: 39
  ident: bib13
  article-title: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
  publication-title: Lancet
– volume: 20
  start-page: 34
  issue: Suppl 4
  year: 2009
  ident: 10.1016/j.surg.2015.11.002_bib11
  article-title: Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdp122
– year: 2015
  ident: 10.1016/j.surg.2015.11.002_bib12
  article-title: Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
  publication-title: Gastric Cancer
– volume: 4
  start-page: 16
  year: 2012
  ident: 10.1016/j.surg.2015.11.002_bib22
  article-title: Lymph node, peritoneal and bone marrow micrometastases in gastric cancer: Their clinical significance
  publication-title: World J Gastrointest Oncol
  doi: 10.4251/wjgo.v4.i2.16
– volume: 7
  start-page: 834
  year: 2007
  ident: 10.1016/j.surg.2015.11.002_bib16
  article-title: Models, mechanisms and clinical evidence for cancer dormancy
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2256
– volume: 65
  start-page: 301
  year: 2003
  ident: 10.1016/j.surg.2015.11.002_bib2
  article-title: Factors influencing recurrence after curative resection for advanced gastric cancer
  publication-title: J Korean Surg Soc
– volume: 51
  start-page: 366
  year: 1994
  ident: 10.1016/j.surg.2015.11.002_bib6
  article-title: Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer
  publication-title: Oncology
  doi: 10.1159/000227367
– volume: 31
  start-page: 3219
  year: 2013
  ident: 10.1016/j.surg.2015.11.002_bib15
  article-title: Apatinib for chemotherapy refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel arm, phase II trial
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2013.48.8585
– volume: 20
  start-page: 282
  year: 2001
  ident: 10.1016/j.surg.2015.11.002_bib19
  article-title: Minimal residual disease in gastrointestinal cancer
  publication-title: Semin Surg Oncol
  doi: 10.1002/ssu.1046
– volume: 1
  start-page: 125
  year: 1998
  ident: 10.1016/j.surg.2015.11.002_bib10
  article-title: Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer
  publication-title: Gastric Cancer
  doi: 10.1007/s101200050006
– volume: 61
  start-page: 69
  year: 2011
  ident: 10.1016/j.surg.2015.11.002_bib1
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.20107
– volume: 20
  start-page: 2005
  year: 2002
  ident: 10.1016/j.surg.2015.11.002_bib23
  article-title: Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow
  publication-title: J Clin Oncol
  doi: 10.1200/jco.2002.08.003
– volume: 356
  start-page: 37
  year: 1982
  ident: 10.1016/j.surg.2015.11.002_bib5
  article-title: Comparison of 5- and 10-year survival rates in operated gastric cancer patients. Assessment of the 5-year survival rate as a valid indicator of postoperative curability
  publication-title: Langenbecks Arch Chir
  doi: 10.1007/BF01270600
– volume: 376
  start-page: 687
  year: 2010
  ident: 10.1016/j.surg.2015.11.002_bib14
  article-title: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)61121-X
– volume: 383
  start-page: 31
  year: 2014
  ident: 10.1016/j.surg.2015.11.002_bib13
  article-title: Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)61719-5
– volume: 14
  start-page: 113
  year: 2011
  ident: 10.1016/j.surg.2015.11.002_bib7
  article-title: Japanese gastric cancer treatment guidelines 2010 (ver. 3)
  publication-title: Gastric Cancer
  doi: 10.1007/s10120-011-0042-4
– volume: 27
  start-page: 481
  year: 2010
  ident: 10.1016/j.surg.2015.11.002_bib8
  article-title: Predictors of timing and patterns of recurrence after curative resection for gastric cancer
  publication-title: Dig Surg
  doi: 10.1159/000320691
– volume: 16
  start-page: 137
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.surg.2015.11.002_bib20
  article-title: Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs
  publication-title: Aliment Pharmacol Ther
  doi: 10.1046/j.1365-2036.16.s2.33.x
– volume: 107
  start-page: 1345
  year: 2012
  ident: 10.1016/j.surg.2015.11.002_bib24
  article-title: Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2012.326
– volume: 155
  start-page: 750
  year: 2013
  ident: 10.1016/j.surg.2015.11.002_bib18
  article-title: Mechanisms governing metastatic dormancy and reactivation
  publication-title: Cell
  doi: 10.1016/j.cell.2013.10.029
– volume: 14
  start-page: 2609
  year: 2008
  ident: 10.1016/j.surg.2015.11.002_bib21
  article-title: Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-4354
– volume: 59
  start-page: 778
  year: 2000
  ident: 10.1016/j.surg.2015.11.002_bib4
  article-title: Clinicopathological characteristics of recurred gastric cancer patients after curative surgery
  publication-title: J Korean Surg Soc
– volume: 14
  start-page: 2730
  year: 2007
  ident: 10.1016/j.surg.2015.11.002_bib3
  article-title: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-007-9479-4
– volume: 87
  start-page: 236
  year: 2000
  ident: 10.1016/j.surg.2015.11.002_bib9
  article-title: Recurrence following curative resection for gastric carcinoma
  publication-title: Br J Surg
  doi: 10.1046/j.1365-2168.2000.01360.x
– volume: 23
  start-page: 573
  year: 2013
  ident: 10.1016/j.surg.2015.11.002_bib17
  article-title: Tumor cell dissemination: emerging biological insights from animal models and cancer patients
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.04.017
– volume: 100
  start-page: 1937
  year: 2009
  ident: 10.1016/j.surg.2015.11.002_bib25
  article-title: Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605085
SSID ssj0009418
Score 2.3407276
Snippet Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this...
Background Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The...
Late recurrence of gastric cancer is rare and there are few data on recurrence in patients who are disease free for >5 years after gastrectomy. The aim of this...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1090
SubjectTerms Adenocarcinoma - diagnosis
Adenocarcinoma - etiology
Adenocarcinoma - mortality
Adenocarcinoma - surgery
Adult
Aged
Disease-Free Survival
Female
Follow-Up Studies
Gastrectomy
Humans
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local - etiology
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Staging
Retrospective Studies
Risk Factors
Stomach Neoplasms - diagnosis
Stomach Neoplasms - etiology
Stomach Neoplasms - mortality
Stomach Neoplasms - surgery
Surgery
Survival Analysis
Time Factors
Title Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection
URI https://www.clinicalkey.com/#!/content/1-s2.0-S003960601500937X
https://www.clinicalkey.es/playcontent/1-s2.0-S003960601500937X
https://dx.doi.org/10.1016/j.surg.2015.11.002
https://www.ncbi.nlm.nih.gov/pubmed/26747230
https://www.proquest.com/docview/1772834443
Volume 159
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELba7YULAvG3pa2MxA2l3Ti2Yx-rimoB0ROV9mbFzrgsQtkq2RXiwrPwLDwZM4mzFWopEsdEGTkej-fHnvmGsde-sqWyUWcBypDJOpisUpQBIGSo0YGvvKF6548Xen4p3y_UYoedjbUwlFaZdP-g03ttnd6cJG6eXC-XVONbkPtNITuG5eVil-0JtPZmwvZO332YX9xg78p8UMiFzYgg1c4MaV7dpr2iDC91TGCe6XTlDvv0N_-zt0Pnj9jD5EDy0-EfH7MdaJ4wiiJ7oKUAfBX5VUXdOAIPtKQtXzY8wad2_NvnFa9a4OliJostAEfHlVPCLadzdK5-_fyO8t_xvn84vx7wKDjVKfVFEE_Z5fnbT2fzLPVRyIISZp3F3NRSixkotEy1iOgSQLRgchmVLLQXoAQQLnuZW2ll4XOMcrT0whhvRG2LZ2zSrBp4wbj3oiotzAKEKEEID1p7tINlJBz3YKcsH7nnQgIZp14XX92YTfbFEccdcRyjD4ccn7I3W5o0pXu_LsZFcWPxKKo7hxbgXqryLiro0o7tXO464WbullRNmdpS_iGY_xzx1SgxDncsXcNUDaw2OBIGNNTdRBZT9nwQpe28hcbwDqPC_f8c9SV7gE96SC06YJN1u4FD9JrW_ojtHv_Ij9Le-A0k1RZO
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELbK9gAXVMTfAgUjcUOhG8d24mNVtdrSdk-ttDcrdsZlK5Stkl2hvk2fhSdjJnEWoZYicU0ycjwez4898w1jn1xpcmWCTjzkPpGVL5JSUQaAkL5CB750BdU7n8309EJ-nav5FjsYamEorTLq_l6nd9o6PtmL3Ny7Xiyoxjcj95tCdgzL8_kjti2pqfWIbe8fn0xnv7F3Zdor5MwkRBBrZ_o0r3bdXFKGl_pCYJ7xdOUe-_Q3_7OzQ0c77Gl0IPl-_4_P2BbUzxlFkR3Qkge-DPyypG4cnnta0oYvah7hU1v-49uSlw3weDGThAaAo-PKKeGW0zk6Vz9vb1D-W971D-fXPR4FpzqlrgjiBbs4Ojw_mCaxj0LilShWSUiLSmoxAYWWqRIBXQIIBopUBiUz7QQoAYTLnqdGGpm5FKMcLZ0oCleIymQv2ahe1vCacedEmRuYePBBghAOtHZoB_NAOO7ejFk6cM_6CDJOvS6-2yGb7MoSxy1xHKMPixwfs88bmjilB7_OhkWxQ_EoqjuLFuBBqvw-Kmjjjm1talthJ_aOVI2Z2lD-IZj_HPHjIDEWdyxdw5Q1LNc4EgY01N1EZmP2qhelzbyFxvAOo8I3_znqB_Z4en52ak-PZydv2RN8o_s0o3dstGrWsIse1Mq9jzvkF7CVGDQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recurrence+of+gastric+cancer+in+patients+who+are+disease-free+for+more+than+5+years+after+primary+resection&rft.jtitle=Surgery&rft.au=Lee%2C+Ju-Hee&rft.au=Kim%2C+Hyun-Il&rft.au=Kim%2C+Min+Gyu&rft.au=Ha%2C+Tae+Kyung&rft.date=2016-04-01&rft.issn=1532-7361&rft.eissn=1532-7361&rft.volume=159&rft.issue=4&rft.spage=1090&rft_id=info:doi/10.1016%2Fj.surg.2015.11.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-6060&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-6060&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-6060&client=summon